Cargando…
Management of direct antiviral agent failures
The current standard of care for patients with chronic hepatitis C virus (HCV) infection is a combination of direct-acting antiviral agents (DAAs). Most HCV patients treated with these drugs achieve viral elimination, but 1% to 15% fail to attain this objective. Treatment failures are usually relate...
Autores principales: | Buti, María, Esteban, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association for the Study of the Liver
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5266337/ https://www.ncbi.nlm.nih.gov/pubmed/28081594 http://dx.doi.org/10.3350/cmh.2016.0107 |
Ejemplares similares
-
New strategies for the treatment of hepatitis C virus infection and implications of resistance to new direct-acting antiviral agents
por: Quer, Josep, et al.
Publicado: (2010) -
Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents
por: Sanduzzi-Zamparelli, Marco, et al.
Publicado: (2019) -
Antiviral Agents against Flavivirus Protease: Prospect and Future Direction
por: Samrat, Subodh K., et al.
Publicado: (2022) -
New era for management of chronic hepatitis C virus using direct antiviral agents: A review
por: Elbaz, Tamer, et al.
Publicado: (2015) -
Curcumin as an Antiviral Agent
por: Jennings, Morgan R., et al.
Publicado: (2020)